Impactibility Model for Population Health Management in High-Cost Elderly Heart Failure Patients: A Capture Method Using the ACG System.


Journal

Population health management
ISSN: 1942-7905
Titre abrégé: Popul Health Manag
Pays: United States
ID NLM: 101481266

Informations de publication

Date de publication:
12 2019
Historique:
pubmed: 24 4 2019
medline: 2 9 2020
entrez: 24 4 2019
Statut: ppublish

Résumé

The aim of the present study is to use the ACG (Adjusted Clinical Groups) System to create an impactibility model by identifying homogeneous clinical subgroups of patients with high risk of an adverse health outcome in a population of heart failure patients with complex health care needs (PCHCN). This method will allow policy makers to target and prioritize services for the highest risk PCHCN in the context of limited health care resources, by identifying relatively homogeneous groups of patients with similar comorbidities. Subjects classified in 2012 as PCHCN in a local health unit by the ACG System were linked with hospital discharge records in 2013. The authors applied the Apriori algorithm to identify the most common sets of the most predictive diseases for the following outcomes of interest: at least 1 admission and at least 1 preventable admission in the year. Predictive performance for the former outcome was compared between the impactability model with the available ACG's individual risk score. The Apriori algorithm also was applied to predict the latter outcome as an example of an event that a policy maker would be able to prevent. Evidence showed no statistically significant difference between the 2 methods. The present model also displayed evidence of good calibration. The Apriori algorithm was applied as an impactibility model, built based on the ACG System, that allowed the authors to obtain an "ACG-based group risk score" and use it to identify clinically homogeneous subgroups of PCHCN. This will help policy makers develop "tool kits" for homogeneous groups of patients that improve health outcomes.

Identifiants

pubmed: 31013467
doi: 10.1089/pop.2018.0190
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

495-502

Auteurs

Alessandra Buja (A)

Department of Cardiologic, Vascular, Thoracic Sciences and Public Health, University of Padova, Padova, Italy.

Michele Rivera (M)

Department of Cardiologic, Vascular, Thoracic Sciences and Public Health, University of Padova, Padova, Italy.

Marta Soattin (M)

Department of Cardiologic, Vascular, Thoracic Sciences and Public Health, University of Padova, Padova, Italy.

Maria Chiara Corti (MC)

Veneto Regional Authority, Venice, Italy.

Francesco Avossa (F)

Veneto Regional Authority, Venice, Italy.

Elena Schievano (E)

Veneto Regional Authority, Venice, Italy.

Stefano Rigon (S)

Veneto Regional Authority, Venice, Italy.

Vincenzo Baldo (V)

Department of Cardiologic, Vascular, Thoracic Sciences and Public Health, University of Padova, Padova, Italy.

Giovanna Boccuzzo (G)

Department of Statistical Sciences, University of Padova, Padova, Italy.

Gianfranco Damiani (G)

Fondazione Policlinico Agostino Gemelli IRCSS. Rome, Italy.
Università Cattolica del Sacro Cuore. Rome, Italy.

Mark H Ebell (MH)

College of Public Health, University of Georgia, Athens, Georgia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH